(Q39004244)

8 September 2017

1 reference

title

Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target (English)

1 reference

8 September 2017

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Li Du

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Ying Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Yang Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jie Zhu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Yi Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

9 November 2016

1 reference

8 September 2017

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

7567-7584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12035-016-0245-0

4 June 2020

exact match

0 references

cites work

Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

ATP mediates rapid microglial response to local brain injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Proteins in microglial activation--inputs and outputs by subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Review: activation patterns of microglia and their identification in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The myeloid cells of the central nervous system parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Fate mapping analysis reveals that adult microglia derive from primitive macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

A lineage of myeloid cells independent of Myb and hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia: Multiple roles in surveillance, circuit shaping, and response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Diversity and plasticity of microglial cells in psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuron-microglia interaction in neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Role of microglia in neurotrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Repertoire of microglial and macrophage responses after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Priming of microglia in a DNA-repair deficient model of accelerated aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Roles of microglia in brain development, tissue maintenance and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Alternatively activated microglia and macrophages in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Generation and characterization of murine alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Restoring immune suppression in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Minocycline selectively inhibits M1 polarization of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial interactions with synapses are modulated by visual experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia promote the death of developing Purkinje cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia and neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Protective effects of microglia in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Phagocytosis of microglia in the central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TREM2 regulates microglial cell activation in response to demyelination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuronal regulation by which microglia enhance the production of neurotrophic factors for GABAergic, catecholaminergic, and cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation - tuning and pruning adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Activated microglia enhance neurogenesis via trypsinogen secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia function during brain development: New insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia regulate the number of neural precursor cells in the developing cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

P2X4R+ microglia drive neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia and intractable chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Review: microglia of the aged brain: primed to be activated and resistant to regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial priming in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Life and death of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Homeostatic and injury-induced microglia behavior in the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia derived from aging mice exhibit an altered inflammatory profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The senescence-associated secretory phenotype: the dark side of tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Decreased neurogenesis in aged rats results from loss of granule cell precursors without lengthening of the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Age-Induced Loss of Mossy Fibre Synapses on CA3 Thorns in the CA3 Stratum Lucidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The microglial sensome revealed by direct RNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Identification of a unique TGF-β-dependent molecular and functional signature in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial cell dysregulation in brain aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation and chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia density decreases with age in a mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

A futility study of minocycline in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Alzheimer's disease risk genes and mechanisms of disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Macrophage colony stimulating factor promotes phagocytosis by murine microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Immunology and immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Ibuprofen, inflammation and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuroinflammatory processes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The influence of microglia on the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Adult glial precursor proliferation in mutant SOD1G93A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

ALS: a disease of motor neurons and their nonneuronal neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1 G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Huntington's disease: from molecular pathogenesis to clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation in presymptomatic Huntington's disease gene carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Early and progressive accumulation of reactive microglia in the Huntington disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Preparing for preventive clinical trials: the Predict-HD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Homogeneity of active demyelinating lesions in established multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial clearance function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Production and functions of IL-17 in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Identification of a microglia phenotype supportive of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Fingolimod modulates microglial activation to augment markers of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Decreased microglial activation in MS patients treated with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Glatiramer acetate: mechanisms of action in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Inhibition of autoimmune encephalomyelitis by a tetracycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Neuroprotective effect of exogenous microglia in global brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglia used as vehicles for both inducible thymidine kinase gene therapy and MRI contrast agents for glioma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Microglial activation in healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0245-0

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Physiology of microglia

1 reference

12 December 2020

CCRL2 regulates M1/M2 polarization during EAE recovery phase

1 reference

12 December 2020

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease

1 reference

12 December 2020

Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning

1 reference

12 December 2020

The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS

1 reference

12 December 2020

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

1 reference

12 December 2020

Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system.

1 reference

12 December 2020

Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice

1 reference

12 December 2020

CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells

1 reference

12 December 2020

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

12 December 2020

Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions

1 reference

12 December 2020

Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers

1 reference

12 December 2020

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

1 reference

12 December 2020

Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms

1 reference

12 December 2020

TREM2 sustains microglial expansion during aging and response to demyelination

1 reference

12 December 2020

Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis

1 reference

12 December 2020

10.1007/S12035-016-0245-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27830532%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference